The pharmacokinetics of methadone in adolescents undergoing posterior spinal fusion

Paediatric Anaesthesia

Volumn 23, Issue 1, 2013, Pages 51-57

  Stemland, Christopher J ^a   Witte, Jurgen ^b   Colquhoun, Douglas A ^a   Durieux, Marcel E ^a   Langman, Loralie J ^c   Balireddy, Ravi ^a   Thammishetti, Swapna ^a   Abel, Mark F ^d   Anderson, Brian J ^e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

children; methadone; pharmacodynamics; pharmacokinetics; scoliosis

Indexed keywords

METHADONE;

ADOLESCENT; ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; HUMAN; IDIOPATHIC SCOLIOSIS; INCISION; MALE; PEDIATRIC SURGERY; POSTERIOR SPINE FUSION; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; CHILD; FEMALE; FOLLOW-UP STUDIES; HALF-LIFE; HUMANS; METHADONE; PROSPECTIVE STUDIES; SCOLIOSIS; SPINAL FUSION; YOUNG ADULT;

EID: 84870880065     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12021     Document Type: Article

References (31)

1. Gottschalk A, Durieux ME, Nemergut EC,. Intraoperative methadone improves postoperative pain control in patients undergoing complex spine surgery. Anesth Analg 2011; 112: 218-223.
2. Berde CB, Beyer JE, Bournaki MC, et al,. Comparison of morphine and methadone for prevention of postoperative pain in 3- to 7-year-old children. J Pediatr 1991; 119: 136-141.
3. Kharasch ED, Hoffer C, Whittington D, et al,. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone. Clin Pharmacol Ther 2004; 76: 250-269.
4. Kearns GL, Abdel-Rahman SM, Alander SW, et al,. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349: 1157-1167.
5. Gourlay GK, Wilson PR, Glynn CJ,. Pharmacodynamics and pharmacokinetics of methadone during the perioperative period. Anesthesiology 1982; 57: 458-467.
6. Gourlay GK, Willis RJ, Wilson PR,. Postoperative pain control with methadone: influence of supplementary methadone doses and blood concentration-response relationships. Anesthesiology 1984; 61: 19-26.
7. Sharma A, Tallchief D, Blood J, et al,. Perioperative pharmacokinetics of methadone in adolescents. Anesthesiology 2011; 115: 1153-1161.
8. Berde CB, Sethna NF, Holzman RS, et al,. Pharmacokinetics of methadone in children and adolescents in the perioperative period. Anesthesiology 1987; 67: A519.
9. Dale O, Hoffer C, Sheffels P, et al,. Disposition of nasal, intravenous, and oral methadone in healthy volunteers. Clin Pharmacol Ther 2002; 72: 536-545.
10. Meresaar U, Nilsson MI, Holmstrand J, et al,. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method. Eur J Clin Pharmacol 1981; 20: 473-478.
11. Inturrisi CE, Colburn WA, Kaiko RF, et al,. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 1987; 41: 392-401.
12. Beal SL, Boeckmann AJ, Sheiner LB, NONMEM Project Group. NONMEM Users Guides. Version V. San Francisco: University of California at San Francisco, 1999.
13. Karlsson MO, Jonsson EN, Wiltse CG, et al,. Assumption testing in population pharmacokinetic models: illustrated with an analysis of moxonidine data from congestive heart failure patients. J Pharmacokin Biopharm 1998; 26: 207-246.
14. Beal S,. Ways to fit a pharmacokinetic model with some data below the quantification limit. J Pharmacokinet Pharmacodyn 2001; 28: 481-504.
15. Ahn JE, Karlsson MO, Dunne A, et al,. Likelihood based approaches to handling data below the quantification limit using NONMEM VI. J Pharmacokinet Pharmacodyn 2008; 35: 401-421.
16. Anderson BJ, Holford NH,. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 2008; 48: 303-332.
17. Anderson BJ, Holford NH,. Mechanistic basis of using body size and maturation to predict clearance in humans. Drug Metab Pharmacokinet 2009; 24: 25-36.
18. Efron B, Tibshirani R,. Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1986; 1: 54-77.
19. Bergstrand M, Hooker AC, Wallin JE, et al,. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. J AAPS 2011; 13: 143-151.
20. Tod M, Jullien V, Pons G,. Facilitation of drug evaluation in children by population methods and modelling. Clin Pharmacokinet 2008; 47: 231-243.
21. Yang F, Tong X, McCarver DG, et al,. Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model. J Pharmacokinet Pharmacodyn 2006; 33: 485-518.
22. Garrido MJ, Troconiz IF,. Methadone: a review of its pharmacokinetic/ pharmacodynamic properties. J Pharmacol Toxicol Methods 1999; 42: 61-66.
23. Garrido MJ, Aguirre C, Troconiz IF, et al,. Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome. Int J Clin Pharmacol Ther 2000; 38: 35-40.
24. Lee LH, Irwin MG, Lui SK,. Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide. Anesthesiology 2005; 102: 398-402.
25. Crawford MW, Hickey C, Zaarour C, et al,. Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery. Anesth Analg 2006; 102: 1662-1667.
26. Inturrisi CE, Portenoy RK, Max MB, et al,. Pharmacokinetic- pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther 1990; 47: 565-577.
27. Court MH, Duan SX, Hesse LM, et al,. Cytochrome P450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. Anesthesiology 2001; 94: 110.
28. Kang D, Schwartz JB, Verotta D,. Sample size computations for PK/PD population models. J Pharmacokinet Pharmacodyn 2005; 32: 685-701.
29. Thomson AH, Elliott HL,. Designing simple PK-PD studies in children. Pediatr Anesth 2011; 21: 190-196.
30. Cortinez LI, Anderson BJ, Penna A, et al,. Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anesth 2010; 105: 448-456.
31. Howie SR,. Blood sample volumes in child health research: review of safe limits. Bull World Health Organ 2011; 89: 46-53.